Neuroscience

Team discovers potential new way to treat anxiety

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects, Vanderbilt University scientists will report next week.

Diseases, Conditions, Syndromes

A new target in the fight against TB

(Medical Xpress)—Researchers have identified a potential new route for attacking tuberculosis that may hold promise against drug-resistant strains of the disease and even dormant TB infections.

Neuroscience

Compound enhances SSRI antidepressant's effects in mice

A synthetic compound is able to turn off "secondary" vacuum cleaners in the brain that take up serotonin, resulting in the "happy" chemical being more plentiful, scientists from the School of Medicine at The University of ...

Psychology & Psychiatry

Preventing suicide: A critical next step

Doctors may in the future be able to take a blood test to determine if a patient is suicidal, hopefully decreasing the number of people taking their own lives.

Oncology & Cancer

Renal cancer cells target of new bark-derived drug

(Medical Xpress)—Associate Professor Joe W. Ramos, PhD, a cancer biologist at the University of Hawai'i Cancer Center in collaboration with Assistant Professor William Chain, PhD, from the UH Mānoa's Chemistry Department ...

Oncology & Cancer

New type of drug leads to hope against resistant ovarian cancer

Scientists at USC have discovered a new type of drug for the treatment of ovarian cancer that works in a way that should not only decrease the number of doses that patients need to take, but also may make it effective for ...

Medications

Popular antidepressant might prevent heart failure

A medication usually used to help treat depression and anxiety disorders has the potential to help prevent heart failure, according to researchers at the University of Michigan.

page 2 from 3